Our Recommendations
New Publications
- NTDs Part 1: Buruli Ulcer, Chagas, Leishmaniasis (2024)
- Chagas Disease Treatment Market Huge Growth in Future Scope 2023-2030 (2023)
- An Update on the Knowledge of Parasite–Vector Interactions of Chagas Disease (2022)
- New Therapeutics for Chagas Disease: Charting a Course to Drug Approval (2022)
- Global, Regional, and National Trends of Chagas Disease from 1990 to 2019: Comprehensive Analysis of the Global Burden of Disease Study (2022)
Filter
45
Featured
Recommendations
2
New Publications
2
Language
Document type
Studies & Reports
15
Guidelines
12
Resource Platforms
6
Fact sheets
5
Strategic & Response Plan
4
Manuals
2
No document type
1
Countries / Regions
Latin America and the Carribbean
22
Global
16
Colombia
4
North America
4
Mexico
2
USA
2
Bolivia
2
China
1
Peru
1
Venezuela
1
Germany
1
Western Pacific Region
1
Western and Central Europe
1
Uruguay
1
Spain
1
Argentina
1
Brazil
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Chagas
45
Disease Prevention & Control
20
Studies & Reports
10
Guidelines
6
Vector Control
5
Health System Strengthening
2
Information, Education and Communication (IEC)
2
Women & Child Health
2
NTDs & Others
2
Pharmacy & Technologies
2
Communicable Diseases
1
Buruli Ulcer
1
Trachoma
1
Lymphaticfilariasis
1
x MEDBOX Issue Brief & Annual Reports x
1
Pediatrics
1
Countries
1
Policies
1
Drugs & Medical Equipment
1
Leprosy
1
Parasitology
1
Leishmaniasis
1
HIV & STI
1
Toolboxes
Chagas
22
Overview, Studies & Reports
11
Clinical Aspects & Diagnostics
9
NTDs
5
Pharmacy
2
Public Health
2
Zoonoses
2
Strategies & Roadmaps
2
Information & Education Material (IEC)
2
Studies & Reports
2
NTDs General
2
Vector control
2
Clinical Guidelines
1
Sustainable Development Goals
1
Dengue & Chikungunya
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Statistics & Facts
1
Statistics & Facts
1
Clinical Aspects & Diagnostics
1
Co-Morbidities (except TB)
1
Zika
1
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
Due to the particular Amazonian situation of vectorial transmission based mostly on the wild cycle of Trypanosoma cruzi with diversity of triatomine vectors involved in effective transmission, and the variety of eco-epidemiological situations that facilitate such transmission, the countries of the A...
El presente decálogo expone de manera concisa los aspectos esenciales de la enfermedad y recoge 10 puntos básicos, esquemáticos y orientados a la práctica para la atención pediátrica de la enfermedad de Chagas.
La Tripanosomiasis Americana o Enfermedad de Chagas es una antropozoonosis,
es decir una enfermedad que afecta tanto al hombre como a numerosos animales
mamíferos y que es producida por un protozoario flagelado de la sangre y de los
tejidos el Trypanosoma cruzi.
The annual celebration of International Chagas Day on the 14th of April highlights the impact of this disease on the global health scenario.
Education and information about Chagas Disease epidemiology and risk factors.
La enfermedad de Chagas, también conocida como tripanosomiasis americana, es causada por el parásito Trypanosoma cruzi. La forma más común de contraer la infección es a través del contacto con las heces de un insecto triatominio (conocido con los nombres de chinche besucona, benchuca, vinchuca...
In 2016, PAHO's Directing Council, through Resolution CD55.R9, approved the “Plan of Action for Elimination of Neglected Infectious Diseases (NID) and Post-Elimination Actions, 2016-2022.” This Resolution urges Member States to implement a set of interventions to reduce the burden of disease by ...
The WHF IASC Roadmap proposes strategies and evidence-based solutions for healthcare professionals, health authorities and governments to help overcome the barriers to comprehensive care for Chagas disease patients. This roadmap describes an ideal patient care pathway, and explores the roadblocks al...
A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform.
Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations s...
Chagas disease, which is caused by infection with the parasite Trypanosoma cruzi, is known as the silent disease. An estimated 8 million people have the disease and most of them do not know that they are infected.
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is
found mainly in endemic areas of 21 Latin American countries. Chagas disease was once entirely
...
Chagas disease is caused by Trypanosoma cruzi, a protozoal organism primarily transmitted by triatomine insect vectors, also known as “kissing bugs.” It is a zoonotic disease originally described by Brazilian physician Dr. Carlos Chagas in 1909 and is widespread in Latin America. Although triato...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Chagas disease (CD) is endemic in the Americas, being present in 21 countries, where it affects about 6 million
people.(1) With such relevant numbers of people affected and disability adjusted life years lost, CD is a poverty-related
and poverty-promoting disease.
Although data describe a relevan...
Bug bites are irritating, and some can be harmful. Learn to identify the type of bug bite and when to seek emergency medical care.
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this background, Novartis is pursuing an end-to-end appro...
American trypanosomiasis, commonly called
Chagas disease (CD), was prevalent once in rural areas
of Latin America where poverty is widespread and was
considered a silent and poorly visible disease. It
has become a global neglected tropical disease and a
significant public health th...
Coherent Market Insights has announced the addition of Chagas Disease Treatment Market 2023 Forecast Analysis by Types, Applications, Size, Share, Key Players, and Regions. a new research report to its market research archive. The Chagas Disease Treatment Market has been thoroughly researched and an...
